Cinfa is a pharmaceutical company with 100% Spanish capital and 55 years of experience, specialising in the development, manufacture and marketing of medicinal products and health solutions. In particular, it provides patients with prescription and non-prescription medicines, mobility and orthopaedic products, personal care treatments and natural solutions based on scientific evidence.

Its wide range of products and the quality, efficacy and safety of its treatments have enabled Cinfa to position itself as the laboratory with the highest number of dispensations in Spanish pharmacies, thereby making it the one the most present in Spanish households, with an average of ten treatments per household.

Cinfa’s solutions are also present in more than a hundred countries around the world, meeting the regulatory requirements and needs of patients in all those different regions.

At a Group level, Cinfa has a team of more than 2,200 professionals, as well as four production plants and two R&D centres in Spain.
Over the last decade, the company has invested more than 400 million euros in R&D and infrastructures to strengthen its medicinal product manufacturing capacity in Spain and to ensure that all patients have access to the medicines they need.

It is consequently committed to sustainable growth, which in recent years has been reflected in its strategy of diversification and internationalisation and in the expansion of its facilities. Moreover, every year it launches an average of 100 new treatments, developed by its R&D team in collaboration with over 70 national and international research centres and universities.